Menu

Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial

By Becerra Carlos,Salazar Ramon,Garcia-Carbonero Rocio,Thomas Anne,Vázquez-Mazón Federico,Cassidy James,Maughan Tim,Castillo Manuel,Iveson Tim,Yin Donghua,Green Stephanie,Bergsland Emily in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Pharmacokinetics of doxorubicin in pregnant women

By Ryu Rachel,Eyal Sara,Kaplan Henry,Akbarzadeh Arezoo,Hays Karen,Puhl Kristin,Easterling Thomas,Berg Stacey,Scorsone Kathleen,Feldman Eric,Umans Jason,Miodovnik Menachem,Hebert Mary in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere

By Soares Heloisa,Bayraktar Soley,Blaya Marcelo,Lopes Gilberto,Merchan Jaime,Macintyre Jessica,Mayo Carlos,Green Mark,Silva Orlando,Levi Joe,Walker Gail,Rocha-Lima Caio in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure

By Rudek Michelle,Chang Cathy,Steadman Kenneth,Johnson Michael,Desai Naveen,Deeken John in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer

By Nakayama Goro,Tanaka Chie,Uehara Keisuke,Mashita Naoki,Hayashi Naomi,Kobayashi Daisuke,Kanda Mitsuro,Yamada Suguru,Fujii Tsutomu,Sugimoto Hiroyuki,Koike Masahiko,Nomoto Shuji,Fujiwara Michitaka,Ando Yuich,Kodera Yasuhiro in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects

By Liu Dongyang,Jiang Ji,Zhang Li,Tan Fenlai,Wang Yingxiang,Zhang Don,Hu Pei in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II clinical trial of PM00104 (Zalypsis^®) in urothelial carcinoma patients progressing after first-line platinum-based regimen

By Castellano Daniel,Bellmunt Joaquim,Maroto José,Font-Pous Albert,Morales-Barrera Rafael,Ghanem Ismael,Suarez Cristina,Martín Lorente Cristina,Etxaniz Olatz,Capdevila Laia,Coronado Cinthya,Alfaro Vicente,Siguero Mariano,Fernández-Teruel Carlos,Carles Joan in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

By Chao Yee,Hsieh Jan-Sing,Yeh Hsien-Tang,Su Yu-Chieh,Wu Cheng-Chung,Chen Jen-Shi,Tai Cheng-Jeng,Bai Li-Yuan,Yeh Kun-Huei,Su Wu-Chou,Li Chung-Pin in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

By Koinis Filippos,Polyzos Aristidis,Christopoulou Athina,Zafeiriou Zafeiris,Emmanouilidis Christos,Papadimitraki Elisavet,Kalykaki Antonia,Kalbakis Kostas,Samonis George,Georgoulias Vassilis in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Population pharmacokinetics and exposure–response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer

By Cosson Valérie,Ng Vivian,Lehle Michaela,Lum Bert in (2014)

Springer Publishing Company

Abstract Access to resources Recommend Favorite